---
title: "Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292765703.md"
description: "A recent patent has been issued that enlarges the company's neural sensing technology platform and enables its entry into the extensive urology market, impacting around 37 million individuals in the United States."
datetime: "2026-07-15T12:02:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292765703.md)
  - [en](https://longbridge.com/en/news/292765703.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292765703.md)
generator: "portal-rs"
---

# Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform

A recent patent has been issued that enlarges the company's neural sensing technology platform and enables its entry into the extensive urology market, impacting around 37 million individuals in the United States.

### Related Stocks

- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)

## Related News & Research

- [Autonomix Medical wins new US patent for feedback-guided precision neuromodulation systems](https://longbridge.com/en/news/297045590.md)
- [GRAPHIC-Traders are bracing for an increasingly hawkish ECB](https://longbridge.com/en/news/296744183.md)
- [BREAKINGVIEWS-Supermaxing prisons protected by minimum security](https://longbridge.com/en/news/296910194.md)
- [H World Group (HTHT) Stock Still Looks Like A Bargain After A 43% Gain](https://longbridge.com/en/news/296844458.md)
- [Keysight Technologies Director Sold Shares Worth Over $957K](https://longbridge.com/en/news/296896196.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**